These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5205536)

  • 21. [Anicteric post-transfusion hepatitis].
    Mudrić V; Mironicki Z; Dimić E; Hadnadev M; Vuković B; Sesler A
    Med Pregl; 1971; 24(11):497-502. PubMed ID: 5140028
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis B and blood transmission (transfusion hepatitis or hospital hepatitis?)].
    Busch H; Eisenhart-Rothe B; Sasse UK
    Infusionstherapie (1973); 1974 Dec; 1(8):633-43. PubMed ID: 4465320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Valve of the estimation of transaminases in blood destined for transfusion].
    German A; Galli A; Jeanmaire J
    Ann Biol Clin (Paris); 1967; 25(5):695-8. PubMed ID: 6059728
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum transaminases: correlation with post-transfusion hepatitis].
    De Battisti C; Carulli N; Barbieri E; Gallo M
    Acta Vitaminol Enzymol; 1968; 22(3):85-9. PubMed ID: 5756731
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis associated antigen (HAA) and the blood transfusion. A follow-up study of recipients of blood from donors with HAA and antibody].
    Heisto H; Julsrud AC; Ulstrup JC; Fagerhol MK
    Tidsskr Nor Laegeforen; 1971 Aug; 91(21):1530-1. PubMed ID: 5569811
    [No Abstract]   [Full Text] [Related]  

  • 26. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion.
    Inaba S; Ito A; Miyata Y; Ishii H; Kajimoto S; Tanaka M; Maruta A; Saito S; Yugi H; Hino M; Tadokoro K
    Transfusion; 2006 Nov; 46(11):2028-9. PubMed ID: 17076860
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
    Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M
    Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis following blood transfusions].
    Busch H
    Dtsch Med Wochenschr; 1971 Nov; 96(47):1851. PubMed ID: 5121116
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transfusion hepatitis and inoculation hepatitis in the laboratory].
    Stampfli K
    Med Lab (Stuttg); 1969 Aug; 22(8):178-86. PubMed ID: 5351057
    [No Abstract]   [Full Text] [Related]  

  • 31. Is postoperative HBV hepatitis in heart transplant recipients the fruit of hazard?
    Cadranel JF; Lunel F; Grippon P; Desruenne M; Moussalli J; Ghoussoub JJ; Cabrol A; Cabrol C; Huraux JM; Opolon P
    Gastroenterol Clin Biol; 1990; 14(11):848-9. PubMed ID: 2276566
    [No Abstract]   [Full Text] [Related]  

  • 32. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
    Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
    [No Abstract]   [Full Text] [Related]  

  • 33. [The risk of hepatitis when using blood and blood products].
    Espmark A
    Lakartidningen; 1972 Dec; 69():Suppl 4:72-5. PubMed ID: 4656853
    [No Abstract]   [Full Text] [Related]  

  • 34. Posttransfusion viral hepatitis (PTVH): myths and facts.
    Alsever JB; Van Schoonhoven PV
    Ariz Med; 1974 Apr; 31(4):263-7. PubMed ID: 4830446
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis following exchange-transfusion].
    Kaftan D; Gladtke E
    Arch Kinderheilkd; 1970; 181(2):119-24. PubMed ID: 5530185
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.
    Matsubayashi K; Nagaoka Y; Sakata H; Sato S; Fukai K; Kato T; Takahashi K; Mishiro S; Imai M; Takeda N; Ikeda H
    Transfusion; 2004 Jun; 44(6):934-40. PubMed ID: 15157263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The problem of transfusion hepatitis. Results and interpretation of transaminase testing in the blood bank services].
    Scheffler WJ; Peschel G; Tänzer SE; Roewer J; Müller S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(3):322-36. PubMed ID: 4176082
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dry plasma production and the hepatitis problem].
    Richter K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(4):320-5. PubMed ID: 4168264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.